91,033 Shares in Pediatrix Medical Group, Inc. (NYSE:MD) Acquired by Aristeia Capital L.L.C.

Aristeia Capital L.L.C. purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 91,033 shares of the company’s stock, valued at approximately $687,000. Aristeia Capital L.L.C. owned approximately 0.11% of Pediatrix Medical Group at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in MD. nVerses Capital LLC acquired a new position in Pediatrix Medical Group in the 2nd quarter worth approximately $31,000. Innealta Capital LLC purchased a new position in shares of Pediatrix Medical Group during the second quarter worth $33,000. Nisa Investment Advisors LLC boosted its holdings in Pediatrix Medical Group by 47.2% in the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after purchasing an additional 1,524 shares during the last quarter. Canada Pension Plan Investment Board acquired a new stake in Pediatrix Medical Group during the 2nd quarter worth about $72,000. Finally, Vanguard Personalized Indexing Management LLC purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $81,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Down 0.8 %

Shares of MD stock opened at $10.48 on Tuesday. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $13.01. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38. The stock’s fifty day moving average is $9.78 and its two-hundred day moving average is $8.83. The firm has a market capitalization of $881.86 million, a P/E ratio of -12.33, a PEG ratio of 1.68 and a beta of 1.56.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.03. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The firm had revenue of $504.30 million for the quarter, compared to analyst estimates of $505.49 million. During the same period in the previous year, the business posted $0.37 earnings per share. Pediatrix Medical Group’s quarterly revenue was up .7% on a year-over-year basis. Research analysts expect that Pediatrix Medical Group, Inc. will post 1.18 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Truist Financial boosted their price target on Pediatrix Medical Group from $8.00 to $10.00 and gave the company a “hold” rating in a report on Thursday, August 15th. UBS Group raised their price target on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the company a “neutral” rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price on the stock in a research note on Friday, June 7th. Finally, StockNews.com raised Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th. Six equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and an average price target of $9.30.

Insider Transactions at Pediatrix Medical Group

In related news, CFO C Marc Richards sold 17,438 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $10.08, for a total value of $175,775.04. Following the completion of the sale, the chief financial officer now owns 175,347 shares of the company’s stock, valued at $1,767,497.76. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CFO C Marc Richards sold 17,438 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $10.08, for a total transaction of $175,775.04. Following the completion of the sale, the chief financial officer now directly owns 175,347 shares in the company, valued at $1,767,497.76. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Laura A. Linynsky sold 7,000 shares of Pediatrix Medical Group stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total transaction of $78,120.00. Following the transaction, the director now directly owns 30,805 shares in the company, valued at $343,783.80. The disclosure for this sale can be found here. Insiders have sold a total of 68,100 shares of company stock worth $701,889 in the last ninety days. Insiders own 2.00% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.